Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL495924 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL2928747 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL494914 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL495661 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL494465 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL494627 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL22612512 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL22612532 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL22612520 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL493872 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113970606-B | Metabolic markers for diagnosing attention deficit hyperactivity disorder syndrome in urine of children | 首都医科大学附属北京儿童医院 | 2022-06-14 | — | — | CN | claimed |
| CN-113970606-A | Metabolic markers for diagnosing attention deficit hyperactivity disorder syndrome in urine of children | 首都医科大学附属北京儿童医院 | 2022-01-25 | — | — | CN | claimed |
| CN-101840785-B | Novel electrolyte | FUJIAN YUNXING ELECTRONICS CO LTD | 2012-08-22 | — | — | CN | claimed |
| CN-101840785-A | Novel electrolyte | FUJIAN YUNXING ELECTRONICS CO LTD | 2010-09-22 | — | — | CN | claimed |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4184225-B1 | OPTICAL FILM | MITSUBISHI GAS CHEMICAL CO (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-12458049-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2025-11-04 | — | — | US | disclosed |
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-20230236340-A1 | OPTICAL FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-07-27 | — | — | US | disclosed |
| EP-4184225-A1 | OPTICAL FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-05-24 | — | — | EP | disclosed |
| CN-115803661-A | Optical film | 三菱瓦斯化学株式会社 | 2023-03-14 | — | — | CN | disclosed |
| US-20220339259-A1 | ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF | SHEN HAIFA (US) | 2022-10-27 | — | — | US | disclosed |
| EP-0832913-A1 | RANDOM SILOXANE COPOLYMER, PROCESS FOR PRODUCTION THEREOF, AND RESIN COMPOSITION CONTAINING THE COPOLYMER | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1998-04-01 | — | — | EP | disclosed |
| EP-0509458-B1 | Multilayer structural material | MITSUBISHI CHEM CORP (JP) | 1996-07-17 | — | — | EP | disclosed |
| US-5328767-A | Polyester with amide groups layer and aromatic polyester or olefin polymer layer for films, sheets and packaging material | MITSUBISHI KASEI CORPORATION (JP) | 1994-07-12 | — | — | US | disclosed |
| EP-0509458-A1 | Multilayer structural material | Mitsubishi Chemical Corporation (JP) | 1992-10-21 | — | — | EP | disclosed |
| US-5102979-A | POLYESTER AND PROCESS FOR PRODUCING THE SAME | MITSUBISHI KASEI CORPORATION (JP) | 1992-04-07 | — | — | US | disclosed |
| EP-0404116-A2 | Polyester and process for producing the same | MITSUBISHI KASEI CORPORATION (JP) | 1990-12-27 | — | — | EP | disclosed |
| US-4782132-A | Process for producing a copolyester | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1988-11-01 | — | — | US | disclosed |
| US-3996292-A | Process for the preparation of aliphatic dialdehydes | RHONE-POULENC S.A. (FR) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458049-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | TSHR 4189/4885LMNA 4020/4885NFKB1 3810/4885 |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | TAS2R7, TAS2R31, TAS2R40 | TSHR 2374/4885LMNA 4221/4885NFKB1 4493/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | TSHR 4189/4885LMNA 4020/4885NFKB1 3810/4885 |
| US-20220339259-A1 | ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF | FABP2, SLC27A1, SLC27A2 | TSHR 4550/4885LMNA 2441/4885NFKB1 2951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.